A propos de cet article
SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2) is a positive-sense single-stranded RNA virus. It caused coronavirus disease 2019 (COVID-19). The B.1.1.529 variant was first reported to WHO from South Africa on 24 November 2021. WHO has designated B.1.1.529 as a VOC, named Omicron. SARS-CoV-2 contains glycosylated spike (S) protein, which is composed of S1 subunit and S2 subunit. The S1 contains a receptor-binding domain (RBD) that can bind to ACE2 receptor on target cells. Neutralizing antibodies against SARS-CoV-2 can block the interaction between SARS-CoV-2 RBD and ACE2. The blocking ability of SARS-CoV-2 neutralizing antibodies is affected by the quantity.This standard product is intended for the calibration of SARS-CoV-2 Omicron neutralizing antibodies. It can be used in the assessment and development of assays for the detection and quantitation of SARS-CoV-2 Omicron neutralizing antibodies. The neutralizing antibody standard binds to multiple neutralizing epitopes in the receptor-binding domain.
- High specificity
- High affinity
- High stability
Genscript offers site-specific neutralizing antibodies, neutralizing antibody standards, and control antibodies.
Type:
Antigen: SARS-CoV-2 RBD
Clonality: Cocktail
Clone:
Conjugation:
Epitope:
Host:
Isotype: IgG
Reactivity:
To order chemicals, medical devices, or other restricted products please provide ID that includes your business name & shipping address via email [email protected] or fax 484.881.5997 referencing your VWR account number. Acceptable forms of ID are:
- • State issued document with your organization's Federal Tax ID Number
- • State issued document with your organization's Resale Tax ID Number
- • City or County issued Business License
- • State Department of Health Services License
- • Any other ID issued by the State that includes the business name & address
* ATTN: California Customers may require additional documentation as part of the CA Health & Safety Code. Products that fall under this regulation will be placed on a mandatory 21-day hold after documentation is received. VWR will not lift restrictions for residential shipping addresses.
Spécifications
- Catalog No:
- 77007-594
- 77007-568
- Antigen name:
- SARS-CoV-2 RBD
- SARS-CoV-2 RBD
- Clonality:
- Cocktail
- Cocktail
- Conjugation:
- Unconjugated
- Unconjugated
- Isotype:
- IgG
- IgG
- Neutralisation:
- Yes
- Yes
- Form:
- Liquid
- Liquid
- Cross adsorption:
- No
- No